BioCentury
ARTICLE | Clinical News

Vimovo regulatory update

November 15, 2010 8:00 AM UTC

The U.K. approved Vimovo from Pozen to treat signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at...